伴侶動物診斷市場規模、佔有率和成長分析（按技術、動物種類、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，伴侶動物診斷市場規模將達到 26.5 億美元，到 2025 年將達到 29 億美元，到 2033 年將達到 59.4 億美元，在預測期（2026-2033 年）內複合年成長率為 9.4%。

寵物慢性病發病率的上升趨勢正在推動伴侶動物診斷技術的進步，尤其是在越來越多的寵物飼主認知到獸醫護理的重要性之後。犬貓糖尿病等疾病的顯著增加便是這一趨勢的例證。犬貓主人數量的成長表明社會對伴侶動物的接受度不斷提高，從而推動了該行業的收入成長。市場對能夠有效處理檢體和進行全面疾病篩檢的自動化和半自動化診斷測試有著巨大的需求。此外，用於早期發現糖尿病的血糖監測技術的普及也推動了市場潛力。對照護現場診斷（POCD）快速檢測的日益重視也在塑造著市場動態，各公司正投資研發創新診斷解決方案以滿足這一不斷成長的需求。

伴侶動物診斷市場促進因素

由於攜帶式診斷工具的興起，伴侶動物診斷市場蓬勃發展，這些工具能夠實現動物疾病的照護現場檢測。領先的製造商正致力於開發這些移動工具，特別是針對第一線獸醫的工具，使他們能夠在家庭、收容所等偏遠地區以及緊急情況下進行診斷。獸醫對即時診斷解決方案日益成長的需求推動了這些可攜式系統的應用。這些系統不僅簡化了資料收集流程，也加強了大規模獸醫診所和研究機構內部各部門之間的溝通。

伴侶動物診斷市場限制因素

伴侶動物診斷市場面臨許多可能阻礙其成長的重大挑戰。寵物照護成本的不斷上漲抑制了飼主尋求必要診斷服務的意願，從而影響了整體需求。此外，發展中地區獸醫短缺加劇了這個問題，限制了動物獲得基本醫療服務的機會。同時，寵物飼主普遍缺乏獸醫知識也阻礙了市場擴張，因為這種知識不足會導致診斷服務的使用率不足。這些因素共同構成了伴侶動物診斷市場成長的重大障礙，需要採取策略性措施來克服這些障礙。

伴侶動物診斷市場趨勢

伴侶動物診斷市場的一個顯著趨勢是，旨在改善寵物診斷設備的研發活性化不斷增加。這主要源自於人們認知到SARS-CoV-2等感染疾病與伴侶動物健康狀況之間存在流行病學聯繫，凸顯了伴侶動物對公共衛生和生物多樣性的重要性。衛生部門之間的合作正在促進對通用的感染疾病傳播進行積極監測，尤其是在與COVID-19陽性患者接觸過的犬貓中。這些努力不僅旨在保護動物健康，也標誌著獸醫診斷正被納入更廣泛的健康監測框架。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析及其影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 案例研究

全球伴侶動物診斷市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 臨床生物化學
  • 臨床化學分析
  • 試劑、夾子、墨盒
  • 分析器
  • 血糖監測
  • 血糖試紙
  • 血糖值監測儀
  • 尿糖試紙
  • 血氣和電解質分析
  • 試劑、夾子、墨盒
  • 血液氣體和電解質分析儀
• 免疫診斷
  • 橫向流動化驗
  • 快速檢測
  • 試紙條閱讀器（側向流讀取儀）
  • ELISA檢測
  • 過敏原特異性免疫診斷試驗
  • 免疫檢測分析儀
  • 用於免疫診斷的其他動物物種
• 血液學
  • 墨水匣
  • 分析器
• 尿液檢查
  • 卡扣式墨盒/面板
  • 尿液分析儀
  • 尿液檢查檢測試紙
• 分子診斷
  • 聚合酵素鏈鎖反應檢測
  • 微陣列
  • 其他用於分子診斷的動物物種
• 其他伴侶動物診斷技術

全球伴侶動物診斷市場規模（以動物類型分類）及複合年成長率（2026-2033 年）

• 狗
• 貓
• 馬
• 其他伴侶動物

全球伴侶動物診斷市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 臨床病理
• 細菌學
• 病毒學
• 寄生蟲學
• 其他用途

全球伴侶動物診斷市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 診斷檢查室
• 獸醫醫院和診所
• 研究機構和大學
• 居家照護環境

全球伴侶動物診斷市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Idexx Laboratories, Inc.
• Zoetis Inc.
• Thermo Fisher Scientific Inc.
• Biomerieux SA
• Virbac
• Neogen Corporation
• Fujifilm Holdings Corporation
• Indical Bioscience GmbH
• Idvet
• Randox Laboratories, Ltd.
• Bionote, Inc.
• Skyla Corporation
• Urit Medical Electronic Co., Ltd.
• Nova Biomedical
• Fassisi GmbH
• Swissavans AG
• Alvedia
• Megacor Veterinary Diagnostics
• Biopanda Reagents Ltd
• Anipoc Ltd
• Ring Biotechnology Co Ltd.

結論與建議

Companion Animal Diagnostics Market size was valued at USD 2.65 Billion in 2024 and is poised to grow from USD 2.9 Billion in 2025 to USD 5.94 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The growing prevalence of chronic health issues in pets is driving advancements in companion animal diagnostics, particularly as more pet owners recognize the importance of veterinary care. Significant rises in conditions such as canine and feline diabetes are indicative of this trend. The increasing number of households with dogs and cats underlines a broader acceptance of companion animals, fostering revenue growth in the sector. There is a notable demand for automated and semi-automated diagnostic tests that facilitate efficient sample handling and comprehensive disorder screening. Additionally, the surge in glucose monitoring capabilities for early diabetes detection enhances market potential. The emphasis on Point of Care Diagnostics (POCD) for quick test results is further shaping market dynamics, as companies invest in innovative diagnostic solutions to meet this burgeoning demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Companion Animal Diagnostics Market Segments Analysis

Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Companion Animal Diagnostics Market

The Companion Animal Diagnostics market is experiencing growth due to the rise of portable diagnostic tools that facilitate point-of-care services for detecting animal illnesses. Leading manufacturers are focusing on developing these mobile tools specifically for field veterinarians, enabling them to conduct diagnostics in remote locations such as homes or shelters, as well as during emergencies. The increasing demand among veterinarians for immediate diagnostic solutions is motivating the adoption of these portable systems, which not only streamline the process of gathering data but also enhance communication across various departments within larger veterinary hospitals and research institutions.

Restraints in the Companion Animal Diagnostics Market

The Companion Animal Diagnostics market faces several significant challenges that may hinder its growth. Rising costs associated with pet care can deter pet owners from seeking necessary diagnostic services, impacting overall demand. Furthermore, a shortage of veterinarians in developing regions compounds this issue, limiting access to essential healthcare for animals. Additionally, a general lack of awareness regarding animal healthcare among pet owners further obstructs market expansion, as insufficient knowledge can lead to underutilization of diagnostic services. These factors combined present formidable barriers to the growth of the Companion Animal Diagnostics market, necessitating strategic approaches to overcome them.

Market Trends of the Companion Animal Diagnostics Market

The Companion Animal Diagnostics market is experiencing a notable trend towards increased research and development aimed at enhancing diagnostic devices for pets. This surge is driven by the recognition of the epidemiological connections between infectious diseases, such as SARS-CoV-2, and the health of companion animals, underscoring their importance in public health and biodiversity. Collaborative efforts among health authorities are facilitating proactive monitoring of potential zoonotic transmissions, especially in cats and dogs in contact with COVID-19-positive individuals. Such initiatives not only aim to safeguard animal health but also highlight the integration of veterinary diagnostics into broader health surveillance frameworks.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Companion Animal Diagnostics Market Size by Type & CAGR (2026-2033)

• Market Overview
• Clinical biochemistry
  • Clinical chemistry analysis
  • Reagents, clips, and cartridges
  • Analyzers
  • Glucose monitoring
  • Blood glucose strips
  • Glucose monitors
  • Urine glucose strips
  • Blood gas electrolyte analysis
  • Reagents, clips, and cartridges
  • Blood gas & electrolyte analyzers
• Immunodiagnostics
  • Lateral flow assays
  • Rapid tests
  • Strip readers (Lateral flow readers)
  • Elisa tests
  • Allergen-specific immunodiagnostic tests
  • Immunoassay analyzers
  • Other immunodiagnostic Animal Types
• Hematology
  • Cartridges
  • Analyzers
• Urinalysis
  • Clips & cartridges/panels
  • Urine Analyzers
  • Urine test strips
• Molecular diagnostics
  • Polymerase chain reaction tests
  • Microarrays
  • Other molecular diagnostic Animal Types
• Other Companion Animal Diagnostic Technologies

Global Companion Animal Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Other companion animals

Global Companion Animal Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Other Applications

Global Companion Animal Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Diagnostic Laboratories
• Veterinary Hospitals & Clinics
• Research Institutes & Universities
• Home-care Settings

Global Companion Animal Diagnostics Market Size & CAGR (2026-2033)

• North America (Technology, Animal Type, Application, End User)
  • US
  • Canada
• Europe (Technology, Animal Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Technology, Animal Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Technology, Animal Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Animal Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Idexx Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indical Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Idvet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skyla Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Urit Medical Electronic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swissavans AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Megacor Veterinary Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anipoc Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ring Biotechnology Co Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation